Literature DB >> 9603206

Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity.

A Yoshioka1, Y Shimizu, G Hirose, H Kitasato, D Pleasure.   

Abstract

Previously, we have demonstrated that cells of the oligodendroglial lineage express non-NMDA glutamate receptor genes and are damaged by kainate-induced Ca2+ influx via non-NMDA glutamate receptor channels, representing oligodendroglial excitotoxicity. We find in the present study that agents that elevate intracellular cyclic AMP prevent oligodendroglial excitotoxicity. After oligodendrocyte-like cells, differentiated from the CG-4 cell line established from rat oligodendrocyte type-2 astrocyte progenitor cells, were exposed to 2 mM kainate for 24 h, cell death was evaluated by measuring activity of lactate dehydrogenase released into the culture medium. Released lactate dehydrogenase increased about threefold when exposed to 2 mM kainate. Kainate-induced cell death was prevented by one of the following agents: adenylate cyclase activator (forskolin), cyclic AMP analogues (dibutyryl cyclic AMP and 8-bromo-cyclic AMP), and cyclic AMP phosphodiesterase inhibitors (3-isobutyl-1-methylxanthine, pentoxifylline, propentofylline, and ibudilast). Simultaneous addition of both forskolin and phosphodiesterase inhibitors prevented the kainate-induced cell death in an additive manner. A remarkable increase in Ca2+ influx (approximately 5.5-fold) also was induced by kainate. The cyclic AMP-elevating agents caused a partial suppression of the kainate-induced increase in Ca2+ influx, leading to a less prominent response of intracellular Ca2+ concentration to kainate. The suppressing effect of forskolin on the kainate-induced Ca2+ influx was partially reversed by H-89, an inhibitor of cyclic AMP-dependent protein kinase. In contrast to this, okadaic acid, an inhibitor of protein phosphatases 1 and 2A, brought about a decrease in the kainate-induced Ca2+ influx. We therefore concluded that cyclic AMP-elevating agents prevented oligodendroglial excitotoxicity by cyclic AMP-dependent protein kinase-dependent protein phosphorylation, resulting in decreased kainate-induced Ca2+ influx.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603206     DOI: 10.1046/j.1471-4159.1998.70062416.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury.

Authors:  Joyce A Benjamins; Liljana Nedelkoska
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

2.  Adrenergic activation attenuates astrocyte swelling induced by hypotonicity and neurotrauma.

Authors:  Nina Vardjan; Anemari Horvat; Jamie E Anderson; Dou Yu; Deborah Croom; Xiang Zeng; Zala Lužnik; Marko Kreft; Yang D Teng; Sergei A Kirov; Robert Zorec
Journal:  Glia       Date:  2016-03-28       Impact factor: 7.452

3.  Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.

Authors:  Amanda Ellis; Julie Wieseler; Jacob Favret; Kirk W Johnson; Kenner C Rice; Steven F Maier; Scott Falci; Linda R Watkins
Journal:  J Pain       Date:  2014-01-09       Impact factor: 5.820

4.  Ibudilast attenuates astrocyte apoptosis via cyclic GMP signalling pathway in an in vitro reperfusion model.

Authors:  K Takuma; E Lee; R Enomoto; K Mori; A Baba; T Matsuda
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

5.  Protection of mature oligodendrocytes by inhibitors of caspases and calpains.

Authors:  Joyce A Benjamins; Liljana Nedelkoska; Edwin B George
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

6.  Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury.

Authors:  Christopher M Whitaker; Eric Beaumont; Michael J Wells; David S K Magnuson; Michal Hetman; Stephen M Onifer
Journal:  Neurosci Lett       Date:  2008-04-08       Impact factor: 3.046

7.  The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain.

Authors:  Annemarie Ledeboer; Tongyao Liu; Jennifer A Shumilla; John H Mahoney; Sharmila Vijay; Matthew I Gross; Joseph A Vargas; Lance Sultzbaugh; Mark D Claypool; Laura M Sanftner; Linda R Watkins; Kirk W Johnson
Journal:  Neuron Glia Biol       Date:  2006-11

8.  Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine.

Authors:  Nazira El-Hage; Myosotys Rodriguez; Elizabeth M Podhaizer; Shiping Zou; Seth M Dever; Sarah E Snider; Pamela E Knapp; Patrick M Beardsley; Kurt F Hauser
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

Review 9.  Melanocortin Regulation of Inflammation.

Authors:  Wei Wang; Dong-Yu Guo; Yue-Jun Lin; Ya-Xiong Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-09       Impact factor: 5.555

Review 10.  In vitro and in vivo pharmacological models to assess demyelination and remyelination.

Authors:  Jean E Merrill
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.